102
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Direct diabetes-related healthcare expenditures in Slovenia: recent evolution and future projections based on population-level data

, , &
Pages 427-436 | Received 03 Oct 2023, Accepted 18 Dec 2023, Published online: 09 Jan 2024

References

  • International Diabetes Federation. IDF diabetes atlas. 10th ed. [Internet]. Brussels Belgium: International Diabetes Federation; 2021 [cited 2023 Sep 1]. Available from: https://www.diabetesatlas.org
  • Saeedi P, Salpea P, Karuranga S, et al. Mortality attributable to diabetes in 20-79 years old adults, 2019 estimates: results from the international diabetes federation diabetes atlas, 9th edition. Diabet Res Clin Pract. 2020;162:108086. doi: 10.1016/j.diabres.2020.108086
  • Harding JL, Pavkov ME, Magliano DJ, et al. Global trends in diabetes complications: a review of current evidence. Diabetologia. 2019;62(1):3–16. doi: 10.1007/s00125-018-4711-2
  • Risk Factors Collaboration E, Sarwar N, Gao P, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215–2222. doi: 10.1016/S0140-6736(10)60484-9
  • Lee R, Wong TY, Sabanayagam C. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis (Lond). 2015;2(1):17. doi: 10.1186/s40662-015-0026-2
  • Cosentino F, Grant PJ, Aboyans V, et al. 2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020;41(2):255–323. doi: 10.1093/eurheartj/ehz486
  • Seuring T, Archangelidi O, Suhrcke M. The economic costs of type 2 diabetes: a global systematic review. PharmacoEconomics. 2015;33(8):811–831. doi: 10.1007/s40273-015-0268-9
  • Nerat T, Kos M. Burden of Type 2 Diabetes from the Healthcare Payer Perspective in Slovenia / Breme Sladkorne Bolezni Tipa 2 S Stališča Plačnika Zdravstvenega Varstva V Sloveniji. Slovenian J Public Health. 2013;52(3):162–180. doi: 10.2478/sjph-2013-0018
  • Paulin S, Kelšin N, Korošec A, et al. Ekonomsko breme sladkorne bolezni v sloveniji 2012 [economic burden of diabetes in Slovenia 2012]. Ljubljana: Nacionalni inštitut za javno zdravje; 2014. Slovenian.
  • Janša K, Bonča P D, Stariha J Prikaz bremena srčno-žilnih dogodkov pri sladkornih bolnikih [presenting the burden of cardiovascular events in diabetic patients]. Paper presented at: Redni strokovni sestanek Združenja endokrinologov Slovenije; 2017 Nov 17–18; Zreče, Slovenia. Slovenian.
  • Grelewska J, Jakubczyk M, Niewada M, et al. The cost of macro- and microvascular diseases in patients with diabetes mellitus in selected central and Eastern European countries. J Health Policy Outcomes Res [Internet]. 2019 1 [cited 2023 Jan 24]. Available from: http://www.jhpor.com/article/2223-the-cost-of-macro–and-microvascular-diseases-in-patients-with-diabetes-mellitus-in-selected-central-and-eastern-european-countries
  • European Observatory on Health Systems and Policies. Slovenia: health system summary, 2022. Brussels: WHO/European observatory on health systems and policies [Internet]; 2022 [cited 2023 Jun 26]. Available from: https://eurohealthobservatory.who.int/publications/i/slovenia-health-system-summary
  • European Commission. Directorate-general for economic and financial affairs. The 2021 ageing report: economic & budgetary projections for the EU member states (2019-2070) [Internet]. Publications Office; 2021 [cited 2023 Jun 26]. Available from: https://economy-finance.ec.europa.eu/publications/2021-ageing-report-economic-and-budgetary-projections-eu-member-states-2019-2070_en#files
  • OECD iLibrary. OECD, Eurostat and World Health Organization. A system of Health accounts 2011 [Internet]. Revised edition. Paris: OECD Publishing; 2017 [cited 2023 Jun 26]. Available from: 10.1787/9789264270985-en
  • OECD. OECD Health Statistics [Internet]. 2023 [cited 2023 Sep 3]. Available from: https://www.oecd.org/els/health-systems/health-data.htm
  • Kähm K, Stark R, Laxy M, et al. Assessment of excess medical costs for persons with type 2 diabetes according to age groups: an analysis of German health insurance claims data. Diabet Med. 2020;37(10):1752–1758. doi: 10.1111/dme.14213
  • Stegbauer C, Falivena C, Moreno A, et al. Costs and its drivers for diabetes mellitus type 2 patients in France and Germany: a systematic review of economic studies. BMC Health Serv Res. 2020;20(1):1043. doi: 10.1186/s12913-020-05897-w
  • Parker ED, Lin J, Mahoney T, et al. Economic costs of diabetes in the U.S. in 2022. Diabetes Care. 2023 Nov 1;47(1):26–43. doi: 10.2337/dci23-0085
  • Alzaid A, Ladrón de Guevara P, Beillat M, et al. Burden of disease and costs associated with type 2 diabetes in emerging and established markets: systematic review analyses. Expert Rev Pharmacoecon Outcomes Res. 2021;21(4):785–798. doi: 10.1080/14737167.2020.1782748
  • Ramzan S, Timmins P, Hasan SS, et al. Cost analysis of type 2 diabetes mellitus treatment in economically developed countries. Expert Rev Pharmacoecon Outcomes Res. 2019;19(1):5–14. doi: 10.1080/14737167.2018.1513790
  • Einarson TR, Acs A, Ludwig C, et al. Economic Burden of Cardiovascular Disease in Type 2 Diabetes: A Systematic Review. Value Health. 2018;21(7):881–890. doi: 10.1016/j.jval.2017.12.019
  • Nacionalni inštitut za javno zdravje [The National Institute of Public Health]: Zdravstveni statistični letopis Slovenije 2020 [Health statistical yearbook of Slovenia 2020] [Internet]. Ljubljana: Nacionalni inštitut za javno zdravje; 2022 [cited 2023 Jun 26]. Available from: https://nijz.si/publikacije/zdravstveni-statisticni-letopis-2020
  • Janša K, Bonča P D, Gavrić D. Analiza ekonomskega bremena sladkorne bolezni v Sloveniji kot podlaga za načrtovanje bodočih stroškov sladkorne bolezni in presojo ukrepov za njeno obvladovanje [analysis of the economic burden of diabetes in Slovenia as a basis for planning the future costs of diabetes and assessing measures for its control]. Paper presented at: 7. Slovenski endokrinološki kongres; 2022 Oct 20–22; Bled, Slovenia. Slovenian.
  • Xie Y, Al-Aly Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol. 2022;10(5):311–321. doi: 10.1016/S2213-8587(22)00044-4
  • Ulrich S, Holle R, Wacker M, et al. Cost burden of type 2 diabetes in Germany: results from the population-based KORA studies. BMJ Open. 2016;6(11):e012527. doi: 10.1136/bmjopen-2016-012527
  • Charbonnel B, Simon D, Dallongeville J, et al. Direct medical costs of type 2 diabetes in France: an insurance claims database analysis. Pharmacoecon Open. 2018;2(2):209–219. doi: 10.1007/s41669-017-0050-3
  • Bommer C, Heesemann E, Sagalova V, et al. The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study. Lancet Diabetes Endocrinol. 2017;5(6):423–430. doi: 10.1016/S2213-8587(17)30097-9
  • Tomic D, Shaw JE, Magliano DJ. The burden and risks of emerging complications of diabetes mellitus. Nat Rev Endocrinol. 2022;18(9):525–539. doi: 10.1038/s41574-022-00690-7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.